Use of Injectable-platelet-rich-fibrin (I-PRF) to Thicken Gingival Phenotype
Periodontoclasia, Gingiva; Injury, Condition
About this trial
This is an interventional treatment trial for Periodontoclasia focused on measuring PRF, I-PRF, Microneedle, Gingival Thickness, Injectable-Platelet-Rich-Fibrin, Platelet Rich Fibrin
Eligibility Criteria
Inclusion Criteria:
- Never smokers
- Had no history of systemic disease
- Aged ≥18 years old
Exclusion Criteria:
- Patients with a history of diabetes mellitus or systemic disease
- Patients who were under any medication that was known to influence periodontal tissues
- Patients with hormonal changes such as pregnancy or lactation
- Toothless individuals
- Patients who were clotting disorders
Sites / Locations
- Zeliha Betül ÖZSAĞIR
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
I-PRF
I-PRF and Microneedling
Venous blood will be taken from the patient every session and I-PRF will be created in the centrifuge.I-PRF injected on one side of bilateral thin gingival thickness.Apply once a week and one month after the end of the injections, the patient will be called to the control.
Venous blood will be taken from the patient every session and I-PRF will be created in the centrifuge.Microneedle application plus I-PRF injected on the other side in patients with bilateral region with thin gingival phenotype.Apply once a week and one month after the end of the injections, the patient will be called to the control.